AlerisLife Inc. Logo

AlerisLife Inc.

ALR

(1.2)
Stock Price

1,32 USD

-7.91% ROA

-15.17% ROE

-1.4x PER

Market Cap.

44.175.252,00 USD

11.44% DER

0% Yield

-3.18% NPM

AlerisLife Inc. Stock Analysis

AlerisLife Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

AlerisLife Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.27x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (50%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-16.59%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-7.07%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-35) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

AlerisLife Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

AlerisLife Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Sell

AlerisLife Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

AlerisLife Inc. Revenue
Year Revenue Growth
2001 229.235.000
2002 522.511.000 56.13%
2003 576.215.000 9.32%
2004 628.005.000 8.25%
2005 757.527.000 17.1%
2006 827.337.000 8.44%
2007 972.924.000 14.96%
2008 1.104.200.000 11.89%
2009 1.192.563.000 7.41%
2010 1.240.728.000 3.88%
2011 1.281.764.000 3.2%
2012 1.350.878.000 5.12%
2013 1.296.787.000 -4.17%
2014 1.328.075.000 2.36%
2015 1.365.410.000 2.73%
2016 1.378.108.000 0.92%
2017 1.396.106.000 1.29%
2018 1.390.394.000 -0.41%
2019 1.415.144.000 1.75%
2020 1.163.742.000 -21.6%
2021 934.593.000 -24.52%
2022 730.636.000 -27.91%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

AlerisLife Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

AlerisLife Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 15.415.000
2002 0 0%
2003 0 0%
2004 20.053.000 100%
2005 27.775.000 27.8%
2006 33.829.000 17.9%
2007 43.373.000 22%
2008 207.536.000 79.1%
2009 231.459.000 10.34%
2010 243.866.000 5.09%
2011 789.341.000 69.11%
2012 263.240.000 -199.86%
2013 257.329.000 -2.3%
2014 269.744.000 4.6%
2015 269.832.000 0.03%
2016 275.183.000 1.94%
2017 281.743.000 2.33%
2018 287.339.000 1.95%
2019 229.370.000 -25.27%
2020 92.286.000 -148.54%
2021 85.718.000 -7.66%
2022 68.060.000 -25.94%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

AlerisLife Inc. EBITDA
Year EBITDA Growth
2001 1.848.000
2002 -11.091.000 116.66%
2003 -3.187.000 -248.01%
2004 7.957.000 140.05%
2005 -73.302.000 110.86%
2006 -102.350.000 28.38%
2007 45.133.000 326.77%
2008 17.952.000 -151.41%
2009 61.270.000 70.7%
2010 44.787.000 -36.8%
2011 38.691.000 -15.76%
2012 61.919.000 37.51%
2013 32.912.000 -88.14%
2014 9.580.000 -243.55%
2015 -3.822.000 350.65%
2016 23.502.000 116.26%
2017 17.062.000 -37.74%
2018 -34.879.000 148.92%
2019 1.868.000 1967.18%
2020 27.696.000 93.26%
2021 5.568.000 -397.41%
2022 -9.676.000 157.54%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

AlerisLife Inc. Gross Profit
Year Gross Profit Growth
2001 156.268.000
2002 339.969.000 54.03%
2003 425.202.000 20.05%
2004 468.113.000 9.17%
2005 573.636.000 18.4%
2006 563.441.000 -1.81%
2007 209.822.000 -168.53%
2008 240.809.000 12.87%
2009 257.634.000 6.53%
2010 286.436.000 10.06%
2011 831.816.000 65.56%
2012 309.162.000 -169.06%
2013 294.799.000 -4.87%
2014 282.987.000 -4.17%
2015 292.112.000 3.12%
2016 297.765.000 1.9%
2017 291.735.000 -2.07%
2018 245.047.000 -19.05%
2019 229.874.000 -6.6%
2020 115.790.000 -98.53%
2021 83.133.000 -39.28%
2022 57.476.000 -44.64%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

AlerisLife Inc. Net Profit
Year Net Profit Growth
2001 527.000
2002 -13.174.000 104%
2003 -7.939.000 -65.94%
2004 3.291.000 341.23%
2005 -84.159.000 103.91%
2006 -116.665.000 27.86%
2007 23.326.000 600.15%
2008 -4.496.000 618.82%
2009 38.330.000 111.73%
2010 23.492.000 -63.16%
2011 64.201.000 63.41%
2012 24.945.000 -157.37%
2013 -2.340.000 1166.03%
2014 -85.406.000 97.26%
2015 -43.083.000 -98.24%
2016 -21.813.000 -97.51%
2017 -20.902.000 -4.36%
2018 -74.083.000 71.79%
2019 -20.570.000 -260.15%
2020 -7.589.000 -171.05%
2021 -29.748.000 74.49%
2022 -34.032.000 12.59%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

AlerisLife Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 1
2002 -17 105.88%
2003 -9 -88.89%
2004 4 400%
2005 -57 105.36%
2006 -41 -40%
2007 7 671.43%
2008 -1 800%
2009 11 109.09%
2010 7 -83.33%
2011 15 60%
2012 5 -200%
2013 0 0%
2014 -18 100%
2015 -9 -112.5%
2016 -4 -100%
2017 -4 0%
2018 -15 71.43%
2019 -4 -250%
2020 0 0%
2021 -1 0%
2022 -1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

AlerisLife Inc. Free Cashflow
Year Free Cashflow Growth
2001 -3.336.000
2002 -43.008.000 92.24%
2003 3.101.000 1486.91%
2004 -26.168.000 111.85%
2005 -162.351.000 83.88%
2006 -232.350.000 30.13%
2007 -34.841.000 -566.89%
2008 -36.031.000 3.3%
2009 -35.067.000 -2.75%
2010 52.895.000 166.3%
2011 -16.668.000 417.34%
2012 -6.649.000 -150.68%
2013 -24.989.000 73.39%
2014 -22.060.000 -13.28%
2015 -19.282.000 -14.41%
2016 -78.861.000 75.55%
2017 -53.976.000 -46.1%
2018 -103.203.000 47.7%
2019 -61.603.000 -67.53%
2020 45.954.000 234.05%
2021 -17.012.000 370.13%
2022 -9.920.000 -71.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

AlerisLife Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 -1.160.000
2002 8.873.000 113.07%
2003 18.913.000 53.09%
2004 337.000 -5512.17%
2005 -56.877.000 100.59%
2006 -181.216.000 68.61%
2007 38.582.000 569.69%
2008 44.791.000 13.86%
2009 28.244.000 -58.59%
2010 107.480.000 73.72%
2011 44.258.000 -142.85%
2012 50.737.000 12.77%
2013 28.777.000 -76.31%
2014 27.856.000 -3.31%
2015 38.389.000 27.44%
2016 -23.442.000 263.76%
2017 17.119.000 236.94%
2018 -54.223.000 131.57%
2019 -4.109.000 -1219.62%
2020 51.381.000 108%
2021 -7.573.000 778.48%
2022 -5.866.000 -29.1%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

AlerisLife Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 2.176.000
2002 51.881.000 95.81%
2003 15.812.000 -228.11%
2004 26.505.000 40.34%
2005 105.474.000 74.87%
2006 51.134.000 -106.27%
2007 73.423.000 30.36%
2008 80.822.000 9.15%
2009 63.311.000 -27.66%
2010 54.585.000 -15.99%
2011 60.926.000 10.41%
2012 57.386.000 -6.17%
2013 53.766.000 -6.73%
2014 49.916.000 -7.71%
2015 57.671.000 13.45%
2016 55.419.000 -4.06%
2017 71.095.000 22.05%
2018 48.980.000 -45.15%
2019 57.494.000 14.81%
2020 5.427.000 -959.41%
2021 9.439.000 42.5%
2022 4.054.000 -132.83%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

AlerisLife Inc. Equity
Year Equity Growth
2001 65.047.000
2002 65.047.000 0%
2003 64.427.000 -0.96%
2004 95.904.000 32.82%
2005 68.804.000 -39.39%
2006 67.430.000 -2.04%
2007 86.822.000 22.34%
2008 85.339.000 -1.74%
2009 139.315.000 38.74%
2010 164.767.000 15.45%
2011 280.194.000 41.2%
2012 306.805.000 8.67%
2013 310.378.000 1.15%
2014 226.782.000 -36.86%
2015 184.452.000 -22.95%
2016 164.266.000 -12.29%
2017 144.994.000 -13.29%
2018 71.169.000 -103.73%
2019 119.981.000 40.68%
2020 210.532.000 43.01%
2021 181.590.000 -15.94%
2022 154.330.000 -17.66%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

AlerisLife Inc. Assets
Year Assets Growth
2001 118.638.000
2002 133.197.000 10.93%
2003 147.370.000 9.62%
2004 222.985.000 33.91%
2005 228.940.000 2.6%
2006 366.411.000 37.52%
2007 360.454.000 -1.65%
2008 412.638.000 12.65%
2009 413.100.000 0.11%
2010 379.794.000 -8.77%
2011 583.477.000 34.91%
2012 571.356.000 -2.12%
2013 590.183.000 3.19%
2014 534.973.000 -10.32%
2015 531.770.000 -0.6%
2016 509.734.000 -4.32%
2017 475.908.000 -7.11%
2018 405.624.000 -17.33%
2019 345.793.000 -17.3%
2020 454.206.000 23.87%
2021 376.277.000 -20.71%
2022 382.538.000 1.64%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

AlerisLife Inc. Liabilities
Year Liabilities Growth
2001 53.591.000
2002 68.150.000 21.36%
2003 82.943.000 17.84%
2004 127.081.000 34.73%
2005 160.136.000 20.64%
2006 298.981.000 46.44%
2007 273.632.000 -9.26%
2008 327.299.000 16.4%
2009 273.785.000 -19.55%
2010 215.027.000 -27.33%
2011 303.283.000 29.1%
2012 264.551.000 -14.64%
2013 279.805.000 5.45%
2014 308.191.000 9.21%
2015 347.318.000 11.27%
2016 345.468.000 -0.54%
2017 330.914.000 -4.4%
2018 334.455.000 1.06%
2019 225.812.000 -48.11%
2020 243.674.000 7.33%
2021 194.687.000 -25.16%
2022 228.208.000 14.69%

AlerisLife Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
29.58
Net Income per Share
-0.94
Price to Earning Ratio
-1.4x
Price To Sales Ratio
0.05x
POCF Ratio
-5.51
PFCF Ratio
-2.6
Price to Book Ratio
0.23
EV to Sales
-0
EV Over EBITDA
-0.37
EV to Operating CashFlow
0.27
EV to FreeCashFlow
0.12
Earnings Yield
-0.71
FreeCashFlow Yield
-0.39
Market Cap
0,04 Bil.
Enterprise Value
0,00 Bil.
Graham Number
11.04
Graham NetNet
-3.3

Income Statement Metrics

Net Income per Share
-0.94
Income Quality
0.25
ROE
-0.15
Return On Assets
-0.08
Return On Capital Employed
-0.03
Net Income per EBT
1.01
EBT Per Ebit
4.68
Ebit per Revenue
-0.01
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.09
Operating Profit Margin
-0.01
Pretax Profit Margin
-0.03
Net Profit Margin
-0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.24
Free CashFlow per Share
-0.54
Capex to Operating CashFlow
1.25
Capex to Revenue
-0.01
Capex to Depreciation
-0.79
Return on Invested Capital
-0.03
Return on Tangible Assets
-0.08
Days Sales Outstanding
19.88
Days Payables Outstanding
16.08
Days of Inventory on Hand
-22.97
Receivables Turnover
18.36
Payables Turnover
22.7
Inventory Turnover
-15.89
Capex per Share
-0.3

Balance Sheet

Cash per Share
2,50
Book Value per Share
5,75
Tangible Book Value per Share
5.75
Shareholders Equity per Share
5.75
Interest Debt per Share
0.71
Debt to Equity
0.11
Debt to Assets
0.06
Net Debt to EBITDA
-8.3
Current Ratio
1.33
Tangible Asset Value
0,18 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
0.11
Working Capital
0,05 Bil.
Intangibles to Total Assets
0
Average Receivables
0,08 Bil.
Average Payables
0,03 Bil.
Average Inventory
-84954000
Debt to Market Cap
0.47

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

AlerisLife Inc. Dividends
Year Dividends Growth

AlerisLife Inc. Profile

About AlerisLife Inc.

AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.

CEO
Mr. Jeffrey C. Leer
Employee
6.800
Address
400 Centre Street
Newton, 02458-2076

AlerisLife Inc. Executives & BODs

AlerisLife Inc. Executives & BODs
# Name Age
1 Ms. Jennifer Babbin Clark
MD, Sec. & Director
70
2 Mr. Stephen Geiger
Vice President & Chief Accounting Officer
70
3 Mr. James Kotarski
Vice President & Chief Information Officer
70
4 Mr. Timothy A. Bonang
Vice President of Investor Relations
70
5 Mr. Jeffrey C. Leer
Pres & Chief Executive Officer
70
6 Mr. Philip Benjamson
Senior Vice President & Chief Operating Officer
70
7 Ms. Susan Dooley
Vice President of Marketing
70
8 Ms. Heather Pereira
Senior Vice President, Treasurer & Chief Financial Officer
70
9 Mr. Adam David Portnoy
Chairman & MD
70
10 Mr. Vijay Moses
Senior Vice President & Gen. Counsel
70

AlerisLife Inc. Competitors